MICROBIAL PULSE DIAGNOSTICS
Microbial Pulse Diagnostics is developing and deploying an innovative NIST technology for the rapid measurement of antimicrobial susceptibility. This technology “takes the pulse” of bacterial cells, sensing changes in their metabolism, motility, and growth after exposure to an effective antibiotic.
MICROBIAL PULSE DIAGNOSTICS
Industry:
Health Diagnostics
Founded:
1982-01-01
Address:
Golden, Colorado, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
337 K USD
Similar Organizations
C4 Therapeutics
C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.
Lia
Lia Diagnostics develops flush-able and eco-friendly pregnancy test.
SomaLogic
SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
UE LifeSciences
UE LifeSciences is a female technology company building preventive oncology solutions for primary care and home.
Founder
Investors List
MassChallenge
MassChallenge investment in Non Equity Assistance - Microbial Pulse Diagnostics
N-STEP (NIST – Science and Technology Entrepreneurship Program)
N-STEP (NIST – Science and Technology Entrepreneurship Program) investment in Grant - Microbial Pulse Diagnostics
National Science Foundation
National Science Foundation investment in Grant - Microbial Pulse Diagnostics